awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33910025-855B971B-F00A-4100-8D68-C0A2EA9E67B4
Q33910025-855B971B-F00A-4100-8D68-C0A2EA9E67B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33910025-855B971B-F00A-4100-8D68-C0A2EA9E67B4
Finding promiscuous old drugs for new uses.
P2860
Q33910025-855B971B-F00A-4100-8D68-C0A2EA9E67B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33910025-855B971B-F00A-4100-8D68-C0A2EA9E67B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d85cacc9e43e3848276b994b839de310a976094
P2860
Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group.